Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nis Halland

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|May 21, 2015
Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product AnabaenopeptinNis Halland, Mark Brönstrup, Jörg Czech, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 InhibitorsNis Halland, Friedemann Schmidt, Tilo Weiss, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2013
The use of virtual screening and differential scanning fluorimetry for the rapid identification of fragments active against MEK1Kwame Amaning, Maryse Lowinski, Francois Vallee, et al.
Nature Communications|May 13, 2022
Molecular basis for inhibiting human glucose transporters by exofacial inhibitorsNan Wang, Shuo Zhang, Yafei Yuan, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|May 21, 2015
Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product AnabaenopeptinNis Halland, Mark Brönstrup, Jörg Czech, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 InhibitorsNis Halland, Friedemann Schmidt, Tilo Weiss, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2013
The use of virtual screening and differential scanning fluorimetry for the rapid identification of fragments active against MEK1Kwame Amaning, Maryse Lowinski, Francois Vallee, et al.
Nature Communications|May 13, 2022
Molecular basis for inhibiting human glucose transporters by exofacial inhibitorsNan Wang, Shuo Zhang, Yafei Yuan, et al.
Pageof 3